Author:
Carter Jordan,David Kevin A.,Kritharis Athena,Evens Andrew M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference65 articles.
1. Surveillance E aERSP. Fast Stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. 2019. https://seer.cancer.gov/statfacts/html/hodg.html.
2. Evens AM, Hong F, Gordon LI, Fisher RI, Bartlett NL, Connors JM, et al. The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496. 2013;161(1):76–86. https://doi.org/10.1111/bjh.12222.
3. Weekes CD, Vose JM, Lynch JC, Weisenburger DD, Bierman PJ, Greiner T, et al. Hodgkin’s disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. 2002;20(4):1087–93. https://doi.org/10.1200/jco.2002.20.4.1087.
4. Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR, et al. Hodgkin’s disease in the elderly: a population-based study. 2002;119(2):432–40. https://doi.org/10.1046/j.1365-2141.2002.03815.x.
5. Landgren O, Algernon C, Axdorph U, Nilsson B, Wedelin C, Porwit-MacDonald A, et al. Hodgkin’s lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. 2003;88(4):438–44.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献